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Introduction
In 1982, the first ABC transporter, the histidine permease
hisP, was cloned and sequenced.1 The ABC transporters
(ABC Traffic ATPases2) now form part of one of the largest
paralogous protein families known. They are highly
conserved across species, they derive energy from the
hydrolysis of ATP,3 play a vital role in cell processes, and are
characterised by their ability to translocate simple ions as
well as complex proteins, even at low concentration, across
the cell membrane. 
The ABC transporters are used either for efflux or influx
(some are involved in both) of solutes against a
concentration gradient. However, they are substrate-specific
and ABC transporters for amino acids, sugars, inorganic
ions, polysaccharides, peptides and even proteins have been
characterised. ABC transporters are involved in many basic
cell functions such as signal transduction and protein
secretion.4
A typical ABC transporter is made up of four parts: two
membrane-associated domains and two ATP-binding
domains. These subunits can be arranged as separate
polypeptides or be fused in a variety of configurations. Both
ATP-binding domains are required for normal function. 
The transmembrane domains are highly hydrophobic3
and consist of multiple α-helical segments that span the
membrane. The ATP-binding domains are characterised in
their primary structure by the presence of the Walker A and
the Walker B motifs.5 The Walker A sequence can be
represented by GXXGXGKS/T, where ‘X’ can vary, and the
Walker B sequence by hhhhD, where ‘h’ stands for
hydrophobic. The Walker B sequence is preceded by a highly
conserved sequence motif, LSGGQ/R/KQR. These conserved
regions are shown in Fig. 1. The motif LSGGQ is considered
to be a signature sequence for these proteins.4
Finegoldia magna (previously Peptostreptococcus magnus) is
known to be a significant human pathogen,6 its main habitat
being human faeces, the urogenital tract and oral and skin
epithelia. It is the most common Gram-positive anaerobic
coccus isolated from clinical samples and is an opportunistic
bacterium. It has been isolated from various sites of the body
such as post-operative wounds, abscesses and ulcers7.
Usually, F. magna is isolated from wounds where other
bacteria are present; however, it has been isolated in pure
culture in clinical samples, indicating that it has a higher
pathogenicity than other species.8
In the diagnostic laboratory, this microorganism is
classified as fastidious and is mostly overlooked in early
cultures. Proper collection of specimens is important, as is its
identification. Most strains of F. magna take more than 48
hours to grow and cultures for anaerobes take up to 48 hours
in most routine microbiology laboratories. Thus, lack of a
proper technique results in these anaerobic infections being
diagnosed late or not at all. 
The aim of this study is to amplify fragments of a gene
encoding an ABC transporter in F. magna by searching
databases for homology in this protein among various
bacteria and other organisms. Furthermore, the
development of a specific polymerase chain reaction (PCR)
method to detect F. magna, based on the unconserved
regions of the ABC transporter sequences, may be possible.
Materials and methods
The ATP-binding motif is the most highly conserved
sequence in all the ABC transporters. GenBank and Swiss-
Prot were interrogated for the ATP-binding ABC transporter
genes in Agrobacterium tumefaciens, Bacillus firmus,
Encephalitozoon intestinalis, Escherichia coli, Haemophilus
influenzae, Campylobacter jejuni, Bacillus subtilis, Staphylococcus
aureus, Streptococcus pyogenes, Salmonella choleraesuis,
Clostridium acetobutylicum and also in Arabidopsis thaliana.
These organisms were chosen on basis of their Gram-stain
appearance and on the ATP-binding ABC transporter genes
that have been cloned. Using the technique of conserved
Use of bioinformatics and PCR in the search for
ABC transporter homology among various bacteria
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produce polymerase chain reaction (PCR) primers for the
amplification of an ABC transporter gene from the
clinically important anaerobe Finegoldia magna. On
sequencing, a 450 base pair amplicon showed homology
with the amino acid transporter of Enterococcus faecalis.
Little sequence data is available for F. magna and the newly
isolated DNA could be a useful tool in the identification of
this organism in clinical specimens.
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sequence amplification (CSA) by PCR,9 the genes encoding
ATP-binding ABC transporters in various microorganisms
were amplified. 
Several sets of degenerate primers were designed
according to the conserved areas of homology in the ATP-
binding motif. The conserved motifs targeted for
amplification for Walker A were GKST (forward) and DEAT
(reverse), and for Walker B the conserved motifs were
AMVFQ (forward) and DEPT (reverse). The primers for
Walker A were forward 5’ GGHAARWSWACW 3’ and
reverse 5’ WGTWGCYTCRTC 3’ and the primers for Walker
B were forward 5’ GCWATGGTWTTYCAA 3’ and reverse 5’
WGTWGGYTCRTC 3’. The codon usage for Micromonas
micros was used as that for F. magna was not available at the
time the study was undertaken. 
The correct combinations of primers used were based on
the sequence alignment of E. coli published by Higgins in
1992. Only two sets of the degenerate primers produced
amplicons. All the primers were tested on the DNA of a
variety of aerobes and anaerobes which was extracted by the
miniprep bacterial genomic DNA method.10
The PCR technique was carried out using standard
Mastermix (Promega, 25 units/mL Thermus aquaticus [Taq]
DNA polymerase, 200 µmol each of dATP, dGTP, dCTP and
dTTP, and 1.5 mmol/L MgCl2). The PCR reaction was carried
out in a 25- µL volume and 1 µL DNA from each anaerobe
and aerobe was used. The negative control included water
instead of DNA. The PCR programme was run for 30 cycles
and the annealing temperature used was 37˚C.
American Type Cell Culture (ATCC) strains of F. magna
(ATCC 29328) and M. micros (ATCC 33270) were used.
Clinical isolates of organisms obtained from patients at
University College London Hospital were also used and
included (anaerobes) F. magna, M. micros (Peptostreptococcus
micros), Peptinophilus asaccharolyticus (Peptostreptococus
assacharolyticus), Anaerococcus prevotii (Peptostreptococcus
prevotii), Peptostreptococcus anaerobius, Prevotella
melaninogenica, Prevotella bivia and Bacteroides fragilis; and
(aerobes) E. coli, Pseudomonas aeruginosa, Enterococcus faecalis,
Staphylococcus aureus, Staphylococcus epidermidis, coagulase-
negative staphylococci and group B streptococci.
The PCR amplicons were separated on 1% agarose gel in
1x Tris-boric acid-EDTA (TBE buffer; 0.45 mol/L Tris, 0.44
mol/L boric acid, 0.5 mol/L EDTA [pH 8.3]) by electrophoresis
for 1 h at 100 V. In addition, some were sent for further
sequencing (Cytomix, Cambridge, UK).
Results
The primers successfully amplified products from the DNA
extracted from both aerobes and anaerobes. The PCR
products that were obtained when using primers for Walker
A were approximately 450 bp in size and are shown in Fig. 2
(anaerobes) and Fig. 3 (aerobes). The PCR products obtained
when using primers for Walker B were approximately 360 bp
in size and are shown in Fig. 4 (anaerobes) and Fig. 5
(aerobes). As more than one product was amplified, only
those reactions that generated a single PCR product were
sent for sequencing (Cytomix, Cambridge, UK).
The two PCR products obtained when using primers for
Walker B were sequenced successfully and are shown in
Bioinformatics, PCR and ABC transporter homology 183
BRITISH JOURNAL OF BIOMEDICAL SCIENCE 2004 61 (4)
Fig. 1. Sequence
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Table 1. Two PCR products obtained using primers for Walker B.
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Table 1. They were first translated into amino acid sequences
and then analysed using the EMBOSS transeq software
(www.ebi.ac.uk/emboss/transeq/). The results of the
translations included the ABC transporter signature
sequence LSGGQ (data not shown).
Discussion
In this study, the ABC transporter genes were amplified
correctly using primer designs based on homology and
conserved sequence amplification. Previously, this technique
was used successfully in the cloning of the glycosidase genes
from the protozoan Tritrichomonas foetus.9
Although the ABC transporter gene sequence in F. magna
should be similar to ABC transporter genes in other
microorganisms, it would be expected to show differences
because the four domains of the ABC transporters are
encoded by different polypeptides. Based on this difference
in sequence, a specific PCR method to detect only the ABC
transporter gene in F. magna can be designed and used as a
diagnostic tool for the rapid identification of F. magna in
clinical samples.
However, the short ATP-binding motifs (Walker motifs) are
known to occur on other types of transporters (eg F-type
ATPases, P-type ATPases and the Ars arsenite/arsenate
export system).11 Interestingly, when the sequences obtained
in this study were translated into amino acid sequences, the
consensus and signature sequence LSGGQ was present.
This special sequence identifies members of the ABC
superfamily.11
Data generated from this study are new, as no information
on ABC transporters for F. magna is currently available in any
bioinformatics database. Interestingly, the F. magna sequence
data showed 63% homology with the ABC transporter in
Clostridium perfringens. The latter is also an anaerobe, which
BRITISH JOURNAL OF BIOMEDICAL SCIENCE 2004 61 (4)
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Fig. 2. PCR products of the anaerobes using Walker A primers. 
Lane 1: 200 bp ladder, lane 2: F. magna ATCC, lane 3: F. magna,
lane 4: M. micros ATCC, lane 5: M. micros, lane 6: Peptinophilus
asaccharolytica , lane 7: Prevotella bivia, lane 8: Peptostreptococcus
anaerobius, lane 9: A. prevotii, lane 10: B. fragilis, lane 11:
Prevotella melaninogenica, lane 12: negative control.
Fig. 3. PCR products of the aerobes using Walker A primers. 
Lane 1: 200 bp ladder, lane 2: E. coli, lane 3: group B
streptococcus, lane 4: S. aureus, lane 5: S. epidermidis, 
lane 6: coagulase-negative staphylococcus, lane 7: E. faecalis,
lane 8: Pseudomonas aeruginosa, lane 9: negative control.
Fig. 4. PCR products of the anaerobes using Walker B primers. 
Lane 1200 bp ladder, lane 2: F. magna ATCC, lane 3: F. magna, 
lane 4: M. micros ATCC, lane 5: M. micros, lane 6: Peptinophilus
asaccharolyticus, lane 7: Prevotella bivia, lane 8: Peptostreptococcus
anaerobius, lane 9: A. prevotii, lane 10: B. fragilis, lane 11:
Prevotella melaninogenica, lane 12: negative control.
Fig. 5. PCR products of the aerobes using Walker B primers. 
Lane 1: 200 bp ladder, lane 2: E. coli, lane 3: group b
streptococcus, lane 4: S. aureus, lane 5: S. epidermidis, lane 6:
coagulase-negative staphylococcus, lane 7: E. faecalis, lane 8:
Pseudomonas aeruginosa, lane 9: negative control.
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suggests that the sequence obtained is genomic information
for F. magna. More importantly, the sequence data showed
59% homology with the ATPase component of the anaerobes
C. acetobutylicum and Thermoanaerobacter tengcongensis. The F.
magna sequence obtained showed 54% homology with the
ABC transporter, more specifically the ATP-binding domain,
of Streptococcus pneumoniae and S. pyogenes. This reflects the
specificity of the primers used in this study.
The sequence obtained from the clinical isolate of F. magna
showed 96% homology with the multidrug-resistance
protein (cel:C54D1.1). Not surprisingly, this clinical isolate
was obtained from a wound infection. 
ABC transporters have been associated with antibiotic
resistance, and multidrug resistance pumps have also been
found in other pathogens.12 ABC transporters actively pump
antibiotics out of the cell, and some that are found in
microorganisms of medical importance have been identified.
One such example is the ABC protein MrsA, which has been
postulated to cause erythromycin resistance in
staphylococci.13 However, not all antibiotic resistance by
export involves ABC proteins.
The sequence data obtained for the amplicon from
Enterococcus faecalis showed 90% homology with the abc gene
coding for an amino acid ABC transporter in an E. faecalis
vancomycin-resistant V583 clinical isolate. Thus, E. faecalis
was identified to the species level and the amplicon obtained
was most probably that of the amino acid ABC transporter. 
Genome research that involves comparative analysis of
ABC transporters in completed microbial genomes will
provide greater insight into their roles and functions. One
such study was carried out by Tomii and Kaneshisa.14 They
analysed various completed genomes and studied the
number of ABC-type ATP-binding proteins that may be
present in Gram-negative bacteria, Gram-positive bacteria,
cyanobacteria and archaea. They also studied the functional
predictions of the ATP-binding proteins. In this way, the
different types and numbers of ABC transporters can be
lodged in a database so that ABC transporters can be
identified in other microorganisms using bioinformatics and
homology. 
Currently, antibiotics are prescribed prophylactically to
the elderly when they undergo dental procedures because
the transfer of F. magna infections to hip prostheses have
occurred in such cases.15 Use of antibiotics in this way will
lead to increasing resistance among the different F. magna
isolates. 
Clearly, in the face of growing antibiotic resistance of
microorganisms, the study of microbial ABC transporters is
of the utmost importance. In this respect, the use of rapid
DNA-based diagnostic tests16 will prove extremely useful. 
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Introduction
Cervical cancer is one of the three major malignancies in
women worldwide1 with half a million new cases diagnosed
each year. In the UK alone there are, on average, 3200 new
cases a year, resulting in approximately 1200 deaths. 
Cervical cancer is the eleventh most common cause of
cancer deaths in women in the UK, representing
approximately 2% of all female cancers. There is strong
epidemiological evidence to show that acquisition of high-
risk human papillomavirus (HPV) phenotypes (i.e., HPV 16,
18, 31 and 33) is important in the development of cervical
cancer,2 and this group has been found in no less than 75%
of cervical tumours.3
As a result of the mass-screening programme in place in
the UK, a substantial decrease in the incidence of cancer
occurred between 1988 and 1997, representing a fall of 42%.
Whereas there were 10.4 cases per 100,000 in 1995, by 1999
the prevalence had dropped to 9.3 per 100,000. 
A significant drop in the number of cancer cases has been
achieved by the implementation of Papanicolaou (Pap) smear
screening, which aims to detect a series of precancerous
cytological changes termed cervical intraepithelial neoplasia
(CIN).4,5 Identifying cervical cytology changes in
conventional Pap smears involves taking a sample of cells
from the transformation zone of the cervix, using a spatula or
cytobrush. The cells collected are transferred to a microscope
slide, fixed in alcohol, stained with a Papanicolaou technique,
and then screened microscopically. 
Identification of pathology in the transformation zone
relies heavily on the skills of cytoscreeners, biomedical
scientists and pathologists; however, the quality of the
preparation can be compromised by the presence of
inflammatory exudate, inadequate cellularity, or failure to
sample the transformation zone adequately. In order to
overcome some of these problems, liquid-based cytology
(LBC) methodology has been developed, in which the
patient’s entire cervical cell sample is rinsed into a vial
containing a preservative, and slides are then prepared for
examination from the fluid sample. The advantages of LBC
include more uniform specimen cellularity and the fact that
there are fewer fields to examine. 
The advantage of the polymerase chain reaction (PCR) 
as a diagnostic tool is its sensitivity, making it an ideal means 
of detecting low copy numbers of HPV DNA. Care and
attention is required to avoid contamination of individual
samples during collection and subsequent processing. 
In theory, 30–40 cycles can produce a million-fold
amplification and the sensitivity is such that a single copy of
HPV DNA can be detected. Samples of DNA isolated from
Pap smears and paraffin wax-embedded specimens may be
used as a template. 
Two sets of primers (GP5+/GP6+6 and MY09 and MY117)
have been used extensively for HPV detection. Numerous
HPV types have been implicated in cervical cancer, although
HPV types 16, 18, 31 and 33 are most common. Thus, to be
able to detect a broad spectrum of HPV types and yet be able
to distinguish individual serotypes, Ting and Manos7
devised a pair of consensus primers that shared interspersed
regions of DNA sequence homology, especially within the
open reading frames (ORF) of the E1 and L1 genes. These
workers identified regions of homology 20–25 bp in length,
from which consensus primers that would amplify DNA
from more than 25 types of genital HPV were designed. 
The primers (MY11 for the positive strand and MY09 for
the negative strand) are degenerate in several positions,
which allows the possibility that more than one nucleotide
Detection of human papillomavirus from 
liquid-based cytology specimens by in-house PCR: 
a pilot study
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The Papanicolaou smear remains the most common
method for the detection of precancerous changes in
cervical cytology. However, the introduction of a liquid-
based cytology (LBC) technique expands the possibility of
cervical intraepithelial neoplasia (CIN) diagnosis, and
permits detection of precancerous changes and human
papillomavirus (HPV) simultaneously. In the pilot study
reported here, using an in-house polymerase chain
reaction (PCR) method, high-grade HPV was detected in
32% of a cohort of 38 patients. This conventional PCR
method could be developed for use on a real-time PCR
platform or in a microtitre-well format and subsequently
automated.
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can be inserted at a specific time. The size of the product
obtained allows determination of the HPV type as shown 
in Table 1. 
As the composition of the LBC medium in which cervical
cells are preserved is unknown, the present study aims to
determine the usefulness of this method in the diagnosis 
of HPV by an in-house PCR amplification method using 
the MY09/MY11 primers described above. Furthermore,
characterisation of products is performed through DNA
sequencing of the amplicons generated. 
Materials and methods
A total of 38 LBC samples were collected randomly from
apparently healthy patients (age range: 18–56; mean: 35
years) undergoing routine cervical cytology.
Oligonucleotide primers for the detection of HPV types
were synthesised and used according to the manufacturer’s
instructions (Invitrogen). The final concentration of primers
used in each reaction was 0.5 µmol/L. 
The sequence of the primers were as follows: MY 11
(positive strand primer) 5’ GCM CAG GGW CAT AAY AAT
GG 3’; MY09 (negative strand primer) 5’ CGT CCM ARR
GGA WAC TGA TC, where M= A + C, R = A + G, W = A +
T, Y = C +T.
DNA was extracted by an in-house method. Briefly, 1 mL
well-mixed LBC fluid from each patient was transferred into
1.5 mL Eppendorf tubes using sterile disposable pipettes.
The tubes were capped and centrifuged at 3500 rpm for 
10 min. The supernatant was removed and 1 mL lysis buffer
(10 mmol/L Tris [pH 7.4] containing 1 mmol/L EDTA, 1% SDS
and 20 µL 10 mg/mL proteinase K) was added to the deposit
containing the cell pellet. The mixture was homogenised by
vortex-mixing and incubated at 65˚C for 1 h. 
The buffer containing proteinase K lyses cervical cells,
which allowed both human and HPV DNA to be extracted.
The tubes were then heated at 95˚C for 1 min to inactivate
the proteinase K, and then cooled. The lysed material was
divided into two Eppendorf tubes, one of which was 
kept at –70˚C for future use. To each of the remaining tubes,
1 mL phenol:chloroform:isoamyl alcohol (25:24:1 [v/v];
Sigma) was added, the contents were mixed and 
centrifuged at 3000 rpm for 10 min. The top layer was
carefully removed and transferred to a new tube and an
equal amount of chloroform was added, mixed and spun at
3000 rpm for 10 min. 
The top layer was removed carefully into a clean tube and
two volumes of cold 95% ethanol and 5 µL 3 mol/L sodium
acetate buffer were added, mixed well and kept in the
freezer at –20˚C for 1 h. This last step permits the
precipitation of DNA. The tube was then spun at 10,000 rpm
for 10 min to pellet the extracted DNA and the supernatant
was removed and discarded. 
Then, 100 µL 70% ethanol was added to the pellet
(without mixing) and the tube spun at 10,000 rpm for 5 min. 
The supernatant was removed and discarded. 100 µL of 95%
ethanol was added to the pellet (without mixing) and
centrifuged at 10,000 rpm for 10 min. The supernatant was
removed and discarded. The pellet was allowed to air dry in
a sterile incubator, following which the DNA pellet was
resuspended carefully in 50 µL sterile distilled water.
HPV DNA amplification was carried out in a Perkin Elmer
480 DNA thermal cycler (Perkin Elmer, Baltimore , USA) and
PCR master mix (Promega, Southampton, UK) was used 
in 25 µL reactions (Table 2). The constituents were added to
a 0.5 mL Eppendorf tube, mixed briefly by vortex-mixing
and then centrifuged at 2500 rpm for 30 sec. The reaction mix
was then overlaid with 20 µL sterile mineral oil, capped, 
and transferred to the thermal cycler for amplification.
Thirty-five cycles of PCR were carried out using the cycling
conditions described in Table 3 
A negative control consisting of water instead of template
DNA and a positive control consisting of DNA extracted
from HeLa 229 cells infected with HPV 18 were also
included. 
Using a micropipette, 10 µL PCR amplicon was removed
carefully from the 0.5 mL Eppendorf tube into a fresh tube
containing 2 µL 6x loading dye (Promega). The mixture was
loaded into the wells of a pre-cast 1% agarose gel in 1x TBE
(89 mmol/L Tris, 89 mmol/L boric acid, 2 mmol/L EDTA [pH
8.3]) submerged in a Bio-Rad electrophoresis tank
containing 1x TBE buffer. Also, 10µL 100 bp DNA ladder
mixed with 2 µL loading dye was included for size
comparison. A voltage of 100 V was applied for 1 h to permit
electrophoretic migration. 
The gel was removed and stained in 100 mL 1x TBE buffer
to which 10 µL (10 mg/mL) ethidium bromide was added.
The gel was allowed to stain for 10 min and then washed 
Human papillomavirus, LBC and in-house PCR 23
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Table 1. Position of first bases and size of HPV.
HPV type First base position Product size 
MY11 primer MY09 primer of L1 gene (bp)
HPV06 6722 7170 448 
HPV11 6707 7155 448
HPV16 6584 7035 451
HPV18 6558 7012 454
HPV33 6539 6987 448 
Table 2. PCR conditions for HPV DNA amplification.
Ingredients Volume (µL) 
Primer MY09 (x10) 1
Primer MY11 (x10) 1 
Template DNA 1.5 
PCR Master Mix 12.5 
Nuclease free water 9 
Total volume 25 
Table 3. Thermal cycling conditions for MY09/11 primers.
Step Temperature (˚C) Time (min)




Final extension 72 5
in distilled water. Ethidium bromide intercalates with the
DNA bases, which then fluoresce under ultraviolet (UV)
light from a transilluminator.
Results
Table 4 illustrates the age distribution of the patients tested. 
Cytopathology
The results of cytopathological examination were presented
as four outcomes: normal (no dyskaryosis), borderline
changes, mild dyskaryosis, moderate-severe dyskaryosis.
The distribution is illustrated in Figure 1. Among the cohort
47% were normal, 16% showed borderline changes
requiring a further smear in six months, 16% showed mild
dyskaryosis and 21% showed moderate to severe
dyskaryosis (CIN 3). 
Molecular detection of HPV
High-grade HPV was detected in 12 out of 38 samples (32%).
The 33–37 age group produced the highest number of
positive samples. Examples of the positive amplicons are
shown in Figure 2. 
Discussion
In the present study, all the patients who had moderate 
or severe dyskaryosis on cytology were also positive for
high-grade HPV by the in-house PCR method used.
However, two cases of mild dyskaryosis did not give a
positive result with PCR. This suggests that either they were
HPV-negative or that the virus was present but not detected
(i.e., they were false-negatives) because HPV load was below
the level of detection for the method. This could be verified
by increasing the amount of target DNA in the amplification
or increasing the number of amplification cycles to 40. 
In contrast, failure to detect HPV could be attributed to the
fact that the set of consensus primers used did not detect
HPV 31, which is also associated with cervical cancer, and
could have been the cause of the dyskaryosis in these two
cases. DNA degradation is another possibility that should be
investigated by using a set of primers that target a
housekeeping gene (e.g., β-actin) in human chromosomal
DNA. However, this would only determine whether or not
integrated viral genes were intact, as it would yield no
information about unintegrated virus. 
Clearly, samples should be analysed with a different set 
of HPV-specific primers but further negative results could 
be interpreted in three ways: either viral DNA was not
present or extraction was inadequate or the product was
degraded. The last possibility is unlikely because all 
the samples were collected and stored under similar
conditions and those that were amplifiable gave a good yield
of amplicons. 
Overall detection rate of high-grade HPV in dyskaryosis
was 86%. This correlates well with the results of other
studies and implies that dyskaryosis in 10% of patients is not
the result of viral infection. Thus, the two negative cases
described may represent patients in whom dyskaryosis was
not a consequence of high-grade HPV infection. 
The purpose of the present study was to evaluate the
performance characteristics of LBC in detecting HPV, as
studies of the ThinPrep system (Cytyc, Boxborough, MA,
USA) have shown that it was possible to detect the presence
of HPV DNA by PCR from patients undergoing routine
cervical cytology examination. Although the composition of
the medium in which the cells are preserved is unclear,
BRITISH JOURNAL OF BIOMEDICAL SCIENCE 2004 61 (1)
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Table 4. Age distribution of patients.
Age group (years) 18-22 23-27 28-32 33-37 38-42 43-47 48-52 53-57
Patient numbers 4 5 6 11 7 1 1 3
Fig. 1. Cervical pathology of the cohort. Fig. 2. Separation of amplicons on 1% agarose gel. Lane 1: 100 bp
DNA (1000 bp standard band indicated); lane 2: positive control;
lane 3: negative control; lanes 4–8: amplicons from patient samples.
The amplicon sizes are slightly less than 500 bp, corresponding to
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nothing present appeared to interfere with the in-house
PCR technique used in the present study. However, in order
to remove potential inhibitors, it is advisable to separate the
cervical cells from the medium by centrifugation, discard the
medium and then wash the cells in isotonic saline before
proceeding to DNA extraction. 
Material isolated from LBC has also been tested in hybrid
capture assays. A study by de Cremoux et al.8 investigated
the efficiency of the Hybrid Capture 2 (HC2; Digene,
Gaithersburg, MD, USA) HPV assay for the detection 
of cervical neoplasia in LBC. All patients were screened 
by both conventional Pap smear and ThinPrep LBC (Cytyc).
HPV DNA was detected in the residual liquid-based
material; however, their results included 111 false-positives
(34 cross-reactions [1.90%] and 77 true false-positive
[4.31%]), which were attributed to a contiguous strong
chemiluminescence signal. Although they concluded that
the HC2 assay was a reliable and sensitive test for HPV DNA
detection, they did not advocate its use for large-scale
screening for cervical neoplasia. 
The in-house method used in the present study did not
produce any false-positive reactions, is suitable for
modification to a microtitre plate format (substituting an
automated capillary detection system for the agarose gel),
and could be adapted for real-time PCR platforms 
to determine viral load.
There are numerous advantages to the use of LBC. 
In addition to detecting precancerous changes in the cells in
solution, adequate material remains on which to test for the
presence of HPV. Although changes in the transformation
zones are caused mainly by HPV, it has been suggested that
other organisms, such as Chlamydia trachomatis9,10 and
Trichomonas vaginalis,11-14 may also be involved. 
Currently, this group is studying the feasibility of
detecting C. trachomatis and T. vaginalis from LBC samples 
by in-house PCR. 
Conclusions
Following National Institute for Clinical Excellence approval
of the use of LBC in the NHS Cervical Screening
Programme,15 the results of the pilot study presented here
show that DNA extracted from the LBC medium can be used
in molecular diagnostics. HPV DNA was detected in 32% 
of the cohort undergoing routine Pap screening and in 
86% of those with dyskaryosis. However, investigation of a
larger cohort is needed in order to fully appreciate the value
of the in-house PCR used, but it is anticipated that a fully
developed and tested in-house PCR would lower the cost 
of HPV testing considerably.
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